Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Polypeptides which bind C-X-C chemokine receptor type 4 (CXCR4) and methods of treating or reducing the risk of fibrosis and cancer

Polypeptides which bind C-X-C chemokine receptor type 4 (CXCR4) and methods of treating or reducing the risk of fibrosis and cancer

US Patent 11142588 · Granted Oct 12, 2021

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies that specifically bind to TL1a and methods of treating gastrointestin2025
Pyridinone- and pyridazinone-based compounds and uses thereof2024
Macrocyclic compounds as proteasome inhibitors2023
Peptidomimetic proteasome inhibitors2023
ILDR2 antagonists and combinations thereof2023
Peptidomimetic proteasome inhibitors2021
Tetrahydronaphthyridinepentanamide integrin antagonists2021
Pyrazoloquinazolinone antitumor agents2021
Amyloid beta oligomer specific binding molecule2021
Amyloid beta oligomer specific binding molecule2021
Antibodies against TL1a and uses thereof2020
CXCR4 binding molecules and methods of use thereof2020